首页> 外文期刊>Human Genetics >Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity.
【24h】

Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity.

机译:位于相同等位基因上的芳基硫酸酯酶A突变对酶活性降低和变色性白细胞营养不良严重性的贡献。

获取原文
获取原文并翻译 | 示例
       

摘要

The occurrence of different mutations on the same arylsulfatase A allele is not uncommon, due to the high frequency of several variants, among which the pseudodeficiency mutations are particularly important. We identified a late infantile metachromatic leukodystrophy patient carrying on one allele the new E253K mutation and the known T391S polymorphism, and on the other allele the common P426L mutation, usually associated with the adult or juvenile form of the disease, and the N350S and *96A>G pseudodeficiency mutations. To analyze the contribution of mutations located on the same allele to enzyme activity reduction, as well as the possible phenotype implications, we performed transient expression experiments using arylsulfatase A cDNAs carrying the identified mutations separately and in combination. Our results indicate that mutants containing multiple mutations cause a greater reduction of ARSA activity than do the corresponding single mutants, the total deficiency likely corresponding to the sum of the reductions attributed to each mutation. Consequently, each mutation may contribute to ARSA activity reduction, and, therefore, to the degree of disease severity. This is particularly important for the alleles containing a disease-causing mutation and the pseudodeficiency mutations: in these alleles pseudodeficiency could play a role in affecting the clinical phenotype.
机译:在同一芳基硫酸酯酶A等位基因上发生不同突变的情况并不罕见,这是由于几种变体的频率很高,其中伪缺陷突变尤为重要。我们确定了一位晚期婴儿异色性白细胞营养不良患者,其一个等位基因带有新的E253K突变和已知的T391S多态性,而另一个等位基因上具有常见的P426L突变,通常与该疾病的成年或幼年形式有关,以及N350S和* 96A > G假缺陷突变。为了分析位于同一等位基因上的突变对酶活性降低的影响以及可能的表型影响,我们使用芳基硫酸酯酶A cDNA分别或组合进行了瞬时表达实验。我们的结果表明,与相应的单个突变体相比,包含多个突变的突变体引起的ARSA活性降低更大,总缺陷可能与每个突变引起的降低总数相符。因此,每个突变都可能导致ARSA活性降低,并因此导致疾病严重程度。这对于包含致病突变和假缺陷突变的等位基因特别重要:在这些等位基因中,假缺陷可能会影响临床表型。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号